Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657)-Reference-Cited by-同舟云学术

Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657)

Published:1999-09 Issue:2-3 Volume:43 Page:179-185
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Gobeil F,Montagne M,Inamura N,Regoli D

Publisher

Elsevier BV

Subject

Pharmacology

Reference12 articles.

1. Non-peptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor;Aramori;Mol. Pharmacol.,1997

2. The identification of an orally active, non-peptide bradykinin B2 receptor antagonist, FR 173657;Asano;Br. J. Pharmacol.,1997

3. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig;Gobeil;Can. J. Physiol. Pharmacol.,1996

4. HOE 140, a new potent and long-acting bradykinin antagonist: in vitro studies;Hock;Br. J. Pharmacol.,1991

5. International Union of Pharmacology Committee on receptor nomenclature and drug classification: XI. Recommendations on terms and symbols in quantitative pharmacology;Jenkinson;Pharmacol. Rev.,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?;European Journal of Medicinal Chemistry;2021-01

2. B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition;Behavioural Brain Research;2015-02

3. A new biolistic intradermal injector;Shock Waves;2013-07-10

4. Impact of kinins in the treatment of cardiovascular diseases;Pharmacology & Therapeutics;2012-07

5. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: An effective bradykinin inactivation pathway;European Journal of Pharmacology;2011-09